Pharmacist bestowed with Le Mamea title

A local pharmacist, Mathew Mualia, was among eight who were bestowed with the honour of the Le Mamea family title over the holiday period.

The Le Mamea title in the Logomaua family clan has, for decades, only had one heir. He is Mr. Mualia's father: Council of Deputies member Le Mamea Ropati Mualia, who had been the title's sole holder for 40 years.

Le Mamea, who was the only local resident to be bestowed with the title, said it was a honour to be shared with his family and local church and broader community.

"Every contribution [you try to make] always comes back to that," he said. 

"God willing it will make me a better example to our village and church community at Matautu Lefaga and to our entire community as a whole."

Among others to receive the title were his sister, Le Mamea Peta Leniu, who is also a pharmacist now based overseas and who was educated at New Zealand's Otago State University. 

The title bestowal was held on December 28 at Matautu.

In addition to his work as the owner of local private pharmacies, Le Mamea has worked widely across the old National Health Service, including on its board, and currently serves as the Chairman of the Government's Pharmacy Council.

Le Mamea is the eldest of seven from parents Le Mamea Ropati Mualia and Maiava Elisa Mualia.

After studying at Queensland University in Australia, he pursued a career as a pharmacist in Samoa.

He is married to Caroline Mualia and they have two daughters, who work overseas as a pharmacist and biochemist respectively and a son, who is preparing to follow in his father's footsteps to study pharmacy. 

A total of eight were honoured with the Le Mamea title:

1. Le Mamea Lemalu Mathew Mualia

2. Le Mamea Lemalu Tuaoitau Pupi

3. Le Mamea Su'a Stan Ah Kam

4. Le Mamea Peta Leniu

5. Le Mamea Tony Tanielu Le Mamea 

6. Le Mamea Faumui Sami

7. Le Mamea Seuta'atia Sooalo

8. Le Mamea Lemalu Faleupolu 

Bg pattern light


Subscribe to Samoa Observer Online

Enjoy access to over a thousand articles per month, on any device as well as feature-length investigative articles.

Ready to signup?